Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries is currently trading at Rs. 381.55, up by 11.00 points or 2.97% from its previous closing of Rs. 370.55 on the BSE.

The scrip opened at Rs. 383.00 and has touched a high and low of Rs. 386.15 and Rs. 378.75 respectively. So far 62998 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 484.10 on 01-Apr-2019 and a 52 week low of Rs. 336.55 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 402.85 and Rs. 336.55 respectively. The current market cap of the company is Rs. 88907.36 crore.

The promoters holding in the company stood at 54.56%, while Institutions and Non-Institutions held 32.96% and 12.48% respectively.

Sun Pharmaceutical Industries has received approval for Rs 1,700 crore share buyback offer at a maximum price of Rs 425 per share from the open market. At the maximum buy-back size and the maximum buy-back price, the indicative maximum number of equity shares to be bought back under the buy-back would be 4 crore equity shares which represents 1.67 per cent of the total number of equity shares of the company.

However, the actual number of equity shares to be bought back during the buy-back will depend upon the actual price paid (excluding the Transaction Costs) for the equity shares bought back and the aggregate actual amount utilised in the buy-back. The board directors of the company at its meeting held on March 17, 2020 has approved the same.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.